Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group

Ashish M. Kamat, Andrea B. Apolo, Marek Babjuk, Trinity J. Bivalacqua, Peter C. Black, Roger Buckley, Matthew T. Campbell, Eva Compérat, Jason A. Efstathiou, Petros Grivas, Shilpa Gupta, Neil J. Kurtz, Donald Lamm, Seth P. Lerner, Roger Li, David J. McConkey, Joan Palou Redorta, Thomas Powles, Sarah P. Psutka, Neal ShoreGary D. Steinberg, Richard Sylvester, J. Alfred Witjes, Matthew D. Galsky

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group'. Together they form a unique fingerprint.

Medicine & Life Sciences